Compare HSDT & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HSDT | SXTC |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 184.5M |
| IPO Year | N/A | 2019 |
| Metric | HSDT | SXTC |
|---|---|---|
| Price | $3.06 | $1.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 724.6K | 199.0K |
| Earning Date | 11-18-2025 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $941,000.00 | ★ $1,740,907.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 87.45 | N/A |
| 52 Week Low | $2.83 | $0.95 |
| 52 Week High | $1,200.00 | $7.84 |
| Indicator | HSDT | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 31.81 | 57.80 |
| Support Level | $3.83 | $1.35 |
| Resistance Level | $4.32 | $1.42 |
| Average True Range (ATR) | 0.40 | 0.08 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 2.63 | 41.30 |
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.